Previous 10 | Next 10 |
Fourth Quarter Net Revenue up 96%; Annual Net Revenue up 82% Establishes 2020 Revenue Guidance at $14.5 to $15.5 Million SOUTH ORANGE, N.J., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq:NEPH), a commercial stage company that develops and sells high performance water purific...
SOUTH ORANGE, NJ, Feb. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it...
Nephros (NASDAQ: NEPH ) has priced its public offering of 937,500 common stock at $8.00 per share, for gross proceeds of ~$7.5M. More news on: Nephros, Inc., Healthcare stocks news, , Stocks on the move, Read more ...
SOUTH ORANGE, NJ, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance water purification products and pathogen detection...
SOUTH ORANGE, NJ, Jan. 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial markets, today announced ...
Nephros (NASDAQ: NEPH ) reports preliminary Q4 and FY 2019 financial results. More news on: Nephros, Inc., Healthcare stocks news, Read more ...
Anticipates $10.3 Million Full-Year Revenue, Approximately 82% Growth Over 2018; Fourth Quarter Year-Over-Year Revenue Growth Approximately 99% SOUTH ORANGE, NJ, Jan. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company th...
The following companies have filed for mixed shelf offerings: More news on: Nephros, Inc., Voyager Therapeutics, Inc., Allogene Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Nephros (NASDAQ: NEPH ): Q3 GAAP EPS of -$0.10 in-line. More news on: Nephros, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Product Revenue up 85% over Q3 2018 Reiterates Full-Year Revenue Guidance of $9.5-10 Million SOUTH ORANGE, NJ, Nov. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq:NEPH), a commercial stage company that develops and sells high performance water purification produ...
News, Short Squeeze, Breakout and More Instantly...
First-Quarter Net Revenue of $3.5 Million; Technology Advancements and Microplastics Capabilities on the Horizon SOUTH ORANGE, NJ - ( NewMediaWire ) - May 09, 2024 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and co...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
SOUTH ORANGE, NJ - ( NewMediaWire ) - May 02, 2024 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its first quarter financial results on Thursday, May 09, 2024 after ...